Claremont Biosolutions
In Brief This Week: Guardant Health, Devyser, Thermo Fisher, Flatiron Health, ERS Genomics, More
News items for the week of Sept. 4, 2023
Gates Foundation Awards Multiple Grants for Omics, Dx Projects in July
Awardees include BioCrucible, PATH, Johns Hopkins University, 4basebio, Atila Biosystems, Essenlix, Claremont Biosolutions, and the KEMRI – Wellcome Trust Research Program.
The test detects a signature molecular marker upregulated by viable bacteria, and will be useful for pediatric, extrapulmonary, and AIDS-related TB.
IncellDx Inks Exclusive Licensing Deal with Claremont BioSolutions
The partners will couple Claremont BioSolutions' enzyme-free tissue homogenization technology with IncellDx's reagents.
Keck Graduate Institute-led Team Begins New NIH Grant to Develop Point-of-Care Tuberculosis MDx
Premium
NEW YORK (GenomeWeb) — A public-private team led by researchers at the Keck Graduate Institute of Life Sciences has been awarded just over $600,000 by the National Institutes of Health for the first year of a four-year project to further develop its point-of-care nucleic acid testing platform for
Dec 8, 2011
Nov 11, 2010